Less Ads, More Data, More Tools Register for FREE

Pin to quick picks61ZU.L Regulatory News (61ZU)

  • There is currently no data for 61ZU

Dividend Declaration

31 Oct 2018 07:00

RNS Number : 7848F
Natwest Markets PLC
31 October 2018
 

 

 

Royal Bank of Scotland Group

 

31st October 2018

 

NatWest Markets Plc Declaration of Interim Dividend

 

NatWest Markets Plc (NatWest Markets) today announces it has declared an interim ordinary dividend payable to its parent company, The Royal Bank of Scotland Group plc (RBSG Group), of 575.70 pence per ordinary share, corresponding to a total payment of £2.3 billion.

 

On a pro forma basis, the dividend reduces NatWest Markets' Common Equity Tier 1 (CET1) ratio as at 30 September 2018 by 5.6% from 22.7% to 17.1%, in line with the RBS Group's internal capital management plan. The dividend does not have any impact on the RBS Group's CET1 ratio.

 

For further information contact:

 

NatWest Markets Investor Relations

Richard Coombs

Head of NatWest Markets Investor Relations

+44 (0) 20 7678 2069

 

RBS Investor Relations:

Matt Waymark

Head of Investor Relations

+44 (0) 20 7672 1758 

 

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, and requirements, financial position, future pension funding requirements, on-going litigation and regulatory investigations, profitability, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "believes", "risk", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK annual report and accounts and interim reports and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

 

 

Legal Entity Identifiers

 

NatWest Markets Plc

 

RR3QWICWWIPCS8A4S074

The Royal Bank of Scotland Group plc

 

2138005O9XJIJN4JPN90

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVEAFEEDSSPFAF
Date   Source Headline
31st Jul 20203:54 pmRNSPublication of Supplementary Reg Doc & Prospectus
31st Jul 20207:00 amRNSInterim Results 2020
11th Jun 20205:15 pmRNSPublication of Supplementary Reg Doc & Prospectus
11th Jun 20208:00 amRNSRBS and NatWest Markets announce appointments
3rd Jun 202012:51 pmRNSPublication of Final Terms
27th May 20209:44 amRNSPublication of Final Terms
20th May 20206:27 pmRNSPublication of Final Terms
18th May 202011:24 amRNSPublication of Final Terms
15th May 20202:45 pmRNSPublication of Final Terms
14th May 20201:55 pmRNSPublication of Supplementary Prospectus
13th May 20202:14 pmRNSRegistration Document and Base Prospectus
1st May 20204:24 pmRNSPublication of Suppl.Prospcts
1st May 20207:02 amRNSQ1 Interim Management Statement
15th Apr 20202:35 pmRNSAmendment of Final Terms
14th Apr 20203:07 pmRNSPublication of Final Terms
9th Apr 20204:21 pmRNSPublication of Final Terms
7th Apr 20205:59 pmRNSPublication of Final Terms
3rd Apr 202011:14 amRNSPublication of Final Terms
1st Apr 202012:48 pmRNSPublication of Final Terms
26th Mar 202010:46 amRNSPublication of Final Terms
16th Mar 20205:14 pmRNSNatWest Markets N.V. 2019 ARA
16th Mar 20202:36 pmRNSPublication of Final Terms
24th Feb 20202:18 pmRNSPublication of Final Terms
17th Feb 20201:20 pmRNSPublication of Supplementary Prospectus
14th Feb 20207:03 amRNSAnnual Financial Report
14th Feb 20207:02 amRNSFinal Results
7th Jan 202011:09 amRNSPublication of Final Terms
27th Dec 201911:26 amRNSPublication of Final Terms
20th Dec 20197:00 amRNSPublication of Suppl.Prospcts
19th Dec 20197:00 amRNSNatWest Markets Change in Executive Directors
16th Dec 20194:42 pmRNSAmendments To Provisions Relating To Interest
6th Dec 20191:16 pmRNSPublication of Final Terms
4th Dec 20192:47 pmRNSPublication of Final Terms
2nd Dec 20193:00 pmRNSPublication of Suppl.Prospcts
29th Nov 20191:28 pmRNSAnnouncement of NatWest Markets N.V. Transfer
21st Nov 20196:29 pmRNSPublication of a Prospectus
19th Nov 20192:33 pmRNSPublication of Final Terms
4th Nov 201912:55 pmRNSPublication of Final Terms
25th Oct 20194:51 pmRNSPublication of Suppl.Prospcts
24th Oct 20197:01 amRNSQ3 Interim Management Statement
18th Oct 20192:50 pmRNSNotice of Redemption
4th Oct 20191:30 pmRNSPublication of Final Terms
13th Sep 20193:53 pmRNSPublication of Final Terms
28th Aug 20192:48 pmRNSPublication of Final Terms
2nd Aug 20192:47 pmRNSPublication of Supplementary Prospectus
2nd Aug 20197:01 amRNSInterim Results 2019
3rd Jul 20195:03 pmRNSPublication of Final Terms
2nd Jul 201912:02 pmRNSPublication of Supplementary Reg Doc & Prospectus
28th Jun 20192:45 pmRNSDividend Declaration
26th Jun 201912:32 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.